PART II.
OTHER INFORMATION  



 Item 1:  



Legal Proceedings  



We are subject to various legal proceedings and claims, which have arisen, in the ordinary course of business.
The risk factors described in our Annual Report on Form 10-K remain applicable to our business.
The risks described in our Annual Report on Form 10-K are not the only risks that we face.
The implementation of tariffs and export controls on our products may have a material impact on our business.
Our business operations and supply chain are global and may be disrupted by the implementation of tariffs and export controls on our products.
On July 6, 2018, the United States Trade Representative imposed a 25% tariff on a list of products, including certain Teradyne products that are made in China and imported into the United States.
We intend to submit requests for exclusion of our products from the tariff, but there is no assurance that our requests will be approved.
We have implemented operational changes that will mitigate the impact of the 25% tariff on the import of our impacted products into the United States.
On July 10, 2018, the United States Trade Representative announced a proposed 10% tariff on many additional products made in China and imported into the United States.
It is uncertain whether this proposed tariff will be implemented and, if implemented, as to the products that will be covered.
On June 29, 2018, the United States Commerce Department announced that it has commenced a review of new export controls focusing on emerging technologies.
Item 2:  



Unregistered Sales of Equity Securities and Use of Proceeds  



In January 2018, our Board of Directors cancelled the December 2016 stock repurchase program and authorized a new stock repurchase program for up to $1.5 billion of common stock.
We intend to repurchase $750 million in 2018.
During the six months ended July 1, 2018, we repurchased 8.8 million shares of common stock for $360.8 million at an average price of $40.82 per share.
54   



Table of Contents 



In December 2016, our Board of Directors approved a $500 million share repurchase authorization, which commenced on January 1, 2017.
During the six months ended July 2, 2017, we repurchased 3.0 million shares of common stock for $94.3 million at an average price of $31.77 per share.
The following table includes information with respect to repurchases we made of our common stock during the three months ended July 1, 2018 (in thousands except per share price):  



  [DATA_TABLE_REMOVED] 



 (1)  



Includes 3,135 shares at an average price of $38.87 withheld from employees for the payment of taxes.
We satisfy U.S. federal and state minimum withholding tax obligations due upon the vesting and the conversion of restricted stock units into shares of our common stock, by automatically withholding from the shares being issued, a number of shares with an aggregate fair market value on the date of such vesting and conversion that would satisfy the minimum withholding amount due.
Item 4:  



Mine Safety Disclosures  



Not Applicable  



 Item 6:  



Exhibits  



  [DATA_TABLE_REMOVED] 



55   



Table of Contents
